TRAVERE THERAPEUTICS, INC. Cost of Services (Deprecated 2018-01-31)
TRAVERE THERAPEUTICS, INC. (TVTX) reported Cost of Services (Deprecated 2018-01-31) of $3.00 thousand for the 3-month period ending 2012-05-31, per its 10-Q filed 2012-08-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2012-08-08
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2012-05-31 was $3.00K, a 0.00% change year-over-year.
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2011-11-30 was $3.00K, a 0.00% change year-over-year.
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2011-08-31 was $3.00K.
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2011-05-31 was $3.00K.
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2012 was $12.00K, a 0.00% change from fiscal 2011.
- TRAVERE THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2011 was $12.00K.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-05-31 | $3.00K 10-Q · filed 2012-08-08 | |||
| 2012-02-29 | $12.00K 10-K · filed 2012-05-24 | |||
| 2011-11-30 | $3.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-11 | $6.00K derived: sum of 2 quarters · filed 2012-06-06 | $9.00K 10-Q · filed 2012-01-11 | $12.00K derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-08-31 | $3.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-06-06 | $6.00K 10-Q/A · filed 2012-06-06 | $9.00K derived: sum of 3 quarters · filed 2012-08-08 | $12.00K derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-05-31 | $3.00K 10-Q · filed 2012-08-08 | $6.00K derived: sum of 2 quarters · filed 2012-08-08 | $9.00K derived: sum of 3 quarters · filed 2012-08-08 | |
| 2011-02-28 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-24 | $6.00K derived: sum of 2 quarters · filed 2012-05-24 | $12.00K 10-K · filed 2012-05-24 | |
| 2010-11-30 | $3.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-11 | $9.00K 10-Q · filed 2012-01-11 | ||
| 2010-08-31 | $6.00K 10-Q/A · filed 2012-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |